Sean E. Harper - Amgen


Last quote by Sean E. Harper

We look forward to working with the FDA to update the label for Repatha, enabling us to more broadly educate physicians and patients of the proven impact of Repatha to reduce cardiovascular
share this quote
Jul 27 2017 Amgen
Find all of Sean E. Harper’s quotes that have been published in 5 different articles on this page. Sean E. Harper’s quotes are organized by date and topic, making it easy for you to compare, for example, what Sean E. Harper has said both recently, and in the past, on a variety of topics. Some of the topics Sean E. Harper likes to comment on include Americans and migraine. Most recently, Sean E. Harper said, “The efficacy results from this study comparing Evenity to an active control are robust. At the same time, the newly observed cardiovascular safety signal will have to be assessed as part of the overall benefit/risk profile for Evenity.”.
Automatically powered by Storyzy
Take our quote verification challenge and find out !

Quotes by Sean E. Harper

Quote Verifier
Check if the quote you read on social networks is authentic
This webpage has been created by a robot: errors and absent quotes cannot be totally avoided

Quote :

Mistake :

Comments :